Medicine & Life Sciences
Apoptosis
100%
Ovarian Neoplasms
82%
Acute Myeloid Leukemia
68%
Topotecan
65%
Poly(ADP-ribose) Polymerase Inhibitors
62%
Neoplasms
59%
Type I DNA Topoisomerase
49%
tipifarnib
46%
Leukemia
43%
Cell Line
43%
Caspases
42%
Cell Death
35%
Farnesyltranstransferase
34%
Poly(ADP-ribose) Polymerases
34%
Etoposide
33%
Proteins
33%
Carcinoma
32%
Cytarabine
32%
Platinum
30%
Peptides
30%
Camptothecin
29%
Homologous Recombination
29%
alvocidib
29%
NSC 680410
29%
rucaparib
28%
veliparib
26%
In Vitro Techniques
25%
Cisplatin
24%
Type II DNA Topoisomerase
24%
Mutation
24%
Peptide Hydrolases
24%
Drug Therapy
23%
Paclitaxel
23%
Irinotecan
23%
Antineoplastic Agents
22%
Pharmaceutical Preparations
22%
Ligands
21%
Therapeutics
21%
DNA
20%
Breast Neoplasms
20%
Precursor Cell Lymphoblastic Leukemia-Lymphoma
20%
Phosphotransferases
20%
Phosphorylation
19%
lonafarnib
19%
Heterografts
19%
Down-Regulation
18%
Carboplatin
18%
Checkpoint Kinase 1
18%
Poisons
17%
Up-Regulation
17%
Chemical Compounds
Apoptotic
52%
Etoposide
28%
Protein
25%
Cell Death
24%
Poly(ADPribose)
20%
Antiapoptotic
19%
Polypeptide
18%
Cleavage
14%
Topotecan
13%
Poison
13%
Resistance
13%
Camptothecin
13%
Antineoplastic Agent
11%
Mutation
10%
Dose
10%
Drug
9%
Imatinib
8%
Refractory
8%
Rucaparib
8%
Phosphotransferase Inhibitor
7%
SN-38
7%
Veliparib
7%
Farnesylation
7%
Reactive Oxygen Metabolite
6%
Cytarabine
6%
Growth Factor
5%
Fragmentation
5%
Proliferative
5%
Colony Stimulating Factor
5%
Histone
5%